Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the ...

Guggenheim analyst Vamil Divan maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target of ...

In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on AbbVie (ABBV – Research Report), with a price target of ...

Guggenheim has recently raised Exelon Corp (EXC) stock to Buy rating, as announced on January 23, 2025, according to Finviz. Earlier, on January 21, 2025, Evercore ISI had raised the stock, setting a ...

Lendlease completed the $320M sale of its U.S. military housing portfolio to Centinel Public Partnerships, an affiliate of ...

Guggenheim maintained a Neutral rating on Johnson & Johnson (NYSE:JNJ) but increased the stock's price target from $162.00 to $166.00. The adjustment follows the release of the company's ...

AstraZeneca PLC (LSE/STO/NASDAQ:LON:AZN), a pharmaceutical giant with a market capitalization of $215.44 billion and impressive gross profit margins of 82.61%, has received a recommendation for ...

A growing number of countries, including American allies, are striking trade deals as the Trump administration erects a higher fence around its global commerce. By Patricia Cohen President Trump ...

Mexico Reaches Deal With U.S. to Delay Trump Tariffs President Trump said he would pause tariffs on Mexico for a month, but levies on Canada and China were still set to take effect on Tuesday ...

Get dialed in every Tuesday & Friday with quick updates on the world of crypto ...